Drugs / Conjugate Pneumococcal Vaccine 20
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06514547 | Jul 2024 → Sep 2028 expected | HIV infectious disease | Hennepin Healthcare Research Institute | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Conjugate Pneumococcal Vaccine 20 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06514547 ↗ |
| Known as | Prevnar20 | “Prevnar20” NCT06514547 ↗ |
| Modality | Vaccine | “Vaccine” NCT06514547 ↗ |